Pitango HealthTech Fund I L.P. 13D/13G Filings for TScan Therapeutics, Inc. (TCRX)

Pitango HealthTech Fund I L.P. 13D and 13G filings for TScan Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-08
06:02 am
Purchase		 2023-12-31 13G TScan Therapeutics, Inc.
TCRX		 Pitango HealthTech Fund I L.P. 2,079,985
4.300%		 1,000,000increase
(+92.59%)		 Filing
2022-02-14
09:38 am
Purchase		 2021-12-31 13G TScan Therapeutics, Inc.
TCRX		 Pitango HealthTech Fund I L.P. 1,079,985
4.600%		 1,079,985increase
(New Position)		 Filing